These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34642805)

  • 21. Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.
    Mungai F; Verrone GB; Bonasera L; Bicci E; Pietragalla M; Nardi C; Berti V; Mazzoni LN; Miele V
    Radiol Med; 2021 Oct; 126(10):1345-1355. PubMed ID: 34181206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of monoexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors.
    Zhang J; Chen Y; Zhang E; Li N; Yuan H; Lang N
    Eur Spine J; 2020 May; 29(5):1112-1120. PubMed ID: 32040617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors.
    Xiang S; Ren J; Xia Z; Yuan Y; Tao X
    BMC Med Imaging; 2021 Dec; 21(1):194. PubMed ID: 34920706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
    Lee SK; Jee WH; Jung CK; Chung YG
    Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours.
    Tao X; Yang G; Wang P; Wu Y; Zhu W; Shi H; Gong X; Gao W; Yu Q
    Dentomaxillofac Radiol; 2017 Aug; 46(6):20160434. PubMed ID: 28299943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
    Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
    Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
    Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
    Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
    Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted and gadolinium-enhanced dynamic MRI in parotid gland tumors.
    Pâris P; Fath L; Schultz P; Veillon F; Riehm S; Severac F; Venkatasamy A
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):391-398. PubMed ID: 35951107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
    Wang YZ; Xian JF; Wang XY; Guo J; Song LY
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors.
    Hu H; Chen L; Zhu LN; Chen W; Su GY; Dou W; Bu SS; Wu FY; Xu XQ
    Eur Radiol; 2022 Feb; 32(2):1087-1094. PubMed ID: 34347158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of MR imaging findings differentiating parotid basal cell adenomas from other parotid tumors.
    Murayama Y; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Yasumatsu R; Yamamoto H; Yabuuchi H; Ishigami K
    Eur J Radiol; 2021 Nov; 144():109980. PubMed ID: 34601323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.
    Zhang W; Zuo Z; Luo N; Liu L; Jin G; Liu J; Su D
    Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):987-995. PubMed ID: 29430614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
    Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
    Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amide proton transfer-weighted magnetic resonance imaging for the differentiation of parotid gland tumors.
    Wang Y; Wang L; Huang H; Ma J; Lin L; Liu L; Song Q; Liu A
    Front Oncol; 2023; 13():1223598. PubMed ID: 37664057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination.
    Xu Z; Zheng S; Pan A; Cheng X; Gao M
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2228-2234. PubMed ID: 31372671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors.
    Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X
    Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
    Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
    J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apparent diffusion coefficient (ADC) histogram analysis: differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging.
    Zhang Z; Song C; Zhang Y; Wen B; Zhu J; Cheng J
    Dentomaxillofac Radiol; 2019 Oct; 48(7):20190100. PubMed ID: 31265331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI.
    Kushwaha M; Kumar J; Garg A; Singh I; Khurana N
    Pol J Radiol; 2023; 88():e203-e215. PubMed ID: 37234459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.